SEI Investments’s Cellebrite CLBT Stock Holding History

SEI Investments’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$915K	Buy	62,683 +31,539	+101%	+$417K	﹤0.01%	2343
2026 Q1	$429K	Sell	31,144 -75,388	-71%	-$1.14M	﹤0.01%	2707
2025 Q4	$1.92M	Buy	106,532 +25,650	+32%	+$461K	﹤0.01%	1871
2025 Q3	$1.5M	Sell	80,882 -74,056	-48%	-$1.16M	﹤0.01%	1803
2025 Q2	$2.48M	Sell	154,938 -174,055	-53%	-$3.1M	﹤0.01%	1565
2025 Q1	$6.39M	Sell	328,993 -79,050	-19%	-$1.66M	0.01%	1163
2024 Q4	$8.99M	Buy	408,043 +124,558	+44%	+$2.4M	0.01%	1031
2024 Q3	$4.77M	Buy	283,485 +141,841	+100%	+$2.1M	0.01%	1304
2024 Q2	$1.69M	Buy	141,644 +20,478	+17%	+$229K	﹤0.01%	1709
2024 Q1	$1.34M	Buy	121,166 +37,408	+45%	+$382K	﹤0.01%	1773
2023 Q4	$725K	Buy	83,758 +15,193	+22%	+$118K	﹤0.01%	1974
2023 Q3	$525K	Buy	68,565 +50,450	+278%	+$379K	﹤0.01%	2095
2023 Q2	$130K	Buy	+18,115	New	+$106K	﹤0.01%	2529

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

SEI Investments's CLBT Position: Q2 2026 in Review

SEI Investments increased its Cellebrite (CLBT) stake by 101% in Q2 2026, buying an estimated $417K and bringing the position to 62,683 shares worth $915K. The position accounts for ﹤0.01% of the portfolio, ranked #2343.

SEI Investments first reported a position in CLBT in Q2 2023 and has held it in 13 quarters since. The position peaked at $8.99M in Q4 2024. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

SEI Investments held 62,683 shares of Cellebrite worth $915K as of Q2 2026.
SEI Investments bought 31,539 Cellebrite shares in Q2 2026, an estimated $417K.
Cellebrite made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2343 holding.
SEI Investments first reported a position in Cellebrite in Q2 2023 and has held it in 13 quarters since.
SEI Investments's Cellebrite position peaked at $8.99M in Q4 2024.
201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.